| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intercellular Signaling Peptides and Proteins | 13 | 2017 | 100 | 3.050 |
Why?
|
| HIV-1 | 18 | 2024 | 755 | 3.020 |
Why?
|
| Virus Replication | 9 | 2024 | 318 | 2.200 |
Why?
|
| Virus Integration | 12 | 2017 | 65 | 1.930 |
Why?
|
| HIV Integrase | 11 | 2017 | 22 | 1.590 |
Why?
|
| Chromatin | 11 | 2017 | 186 | 1.330 |
Why?
|
| Cell Line | 21 | 2019 | 1410 | 1.020 |
Why?
|
| Transcription Factors | 6 | 2016 | 735 | 0.890 |
Why?
|
| Adaptor Proteins, Signal Transducing | 5 | 2016 | 213 | 0.830 |
Why?
|
| Fullerenes | 3 | 2021 | 31 | 0.790 |
Why?
|
| Sequence Deletion | 3 | 2017 | 93 | 0.670 |
Why?
|
| Host-Pathogen Interactions | 2 | 2019 | 209 | 0.650 |
Why?
|
| Viral Proteins | 4 | 2025 | 190 | 0.620 |
Why?
|
| DNA, Viral | 3 | 2017 | 311 | 0.620 |
Why?
|
| Flavivirus Infections | 1 | 2019 | 5 | 0.610 |
Why?
|
| Retroviridae | 2 | 2012 | 25 | 0.610 |
Why?
|
| Avian leukosis virus | 3 | 2016 | 7 | 0.600 |
Why?
|
| Flavivirus | 1 | 2019 | 16 | 0.600 |
Why?
|
| Anti-HIV Agents | 3 | 2021 | 486 | 0.580 |
Why?
|
| DNA, Complementary | 2 | 2017 | 196 | 0.570 |
Why?
|
| Nuclear Proteins | 2 | 2019 | 333 | 0.530 |
Why?
|
| Viruses | 1 | 2017 | 39 | 0.530 |
Why?
|
| Small Molecule Libraries | 1 | 2017 | 62 | 0.520 |
Why?
|
| High Mobility Group Proteins | 1 | 2016 | 5 | 0.500 |
Why?
|
| Transcriptional Elongation Factors | 1 | 2016 | 8 | 0.500 |
Why?
|
| Heterochromatin | 1 | 2016 | 19 | 0.490 |
Why?
|
| HIV Integrase Inhibitors | 1 | 2016 | 11 | 0.490 |
Why?
|
| Antiviral Agents | 2 | 2017 | 195 | 0.490 |
Why?
|
| RNA Interference | 6 | 2009 | 247 | 0.480 |
Why?
|
| DNA-Binding Proteins | 4 | 2016 | 561 | 0.440 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2017 | 279 | 0.440 |
Why?
|
| Gene Knockdown Techniques | 2 | 2019 | 189 | 0.420 |
Why?
|
| Drosophila Proteins | 1 | 2016 | 188 | 0.420 |
Why?
|
| HIV | 3 | 2009 | 100 | 0.410 |
Why?
|
| Virion | 4 | 2021 | 75 | 0.390 |
Why?
|
| Protein Binding | 8 | 2025 | 1082 | 0.380 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2012 | 79 | 0.380 |
Why?
|
| Transcription, Genetic | 2 | 2012 | 592 | 0.370 |
Why?
|
| Humans | 31 | 2025 | 43102 | 0.360 |
Why?
|
| Lentivirus | 3 | 2008 | 24 | 0.350 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2024 | 113 | 0.340 |
Why?
|
| Protein Interaction Mapping | 1 | 2011 | 65 | 0.330 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2010 | 13 | 0.320 |
Why?
|
| SUMO-1 Protein | 1 | 2010 | 16 | 0.320 |
Why?
|
| Ubiquitins | 1 | 2010 | 47 | 0.320 |
Why?
|
| Promoter Regions, Genetic | 2 | 2010 | 526 | 0.310 |
Why?
|
| Serine | 1 | 2009 | 79 | 0.310 |
Why?
|
| Transcriptional Activation | 1 | 2010 | 173 | 0.300 |
Why?
|
| Antigens, Viral | 3 | 2025 | 48 | 0.290 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2025 | 32 | 0.270 |
Why?
|
| Integrases | 2 | 2004 | 28 | 0.270 |
Why?
|
| Antigen Presentation | 2 | 2025 | 58 | 0.270 |
Why?
|
| HIV Protease Inhibitors | 2 | 2016 | 24 | 0.250 |
Why?
|
| Cells, Cultured | 5 | 2017 | 1621 | 0.230 |
Why?
|
| Proteasome Endopeptidase Complex | 2 | 2009 | 116 | 0.220 |
Why?
|
| Codon | 2 | 2024 | 39 | 0.220 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2019 | 186 | 0.220 |
Why?
|
| Cytomegalovirus Infections | 1 | 2025 | 28 | 0.220 |
Why?
|
| Cytomegalovirus | 1 | 2025 | 45 | 0.220 |
Why?
|
| Oncogenic Viruses | 1 | 2004 | 2 | 0.220 |
Why?
|
| Endoribonucleases | 1 | 2024 | 25 | 0.210 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2025 | 184 | 0.210 |
Why?
|
| RNA, Messenger | 3 | 2024 | 1271 | 0.200 |
Why?
|
| Protein Biosynthesis | 1 | 2024 | 132 | 0.200 |
Why?
|
| Chickens | 2 | 2016 | 161 | 0.200 |
Why?
|
| Caveolins | 1 | 2002 | 9 | 0.190 |
Why?
|
| Genome, Viral | 2 | 2021 | 119 | 0.190 |
Why?
|
| Nucleocapsid Proteins | 1 | 2021 | 12 | 0.180 |
Why?
|
| Cell Survival | 3 | 2016 | 945 | 0.180 |
Why?
|
| Nuclear Localization Signals | 3 | 2006 | 15 | 0.170 |
Why?
|
| gag Gene Products, Human Immunodeficiency Virus | 2 | 2021 | 19 | 0.170 |
Why?
|
| Gene Expression | 2 | 2019 | 701 | 0.160 |
Why?
|
| RNA, Viral | 1 | 2021 | 321 | 0.160 |
Why?
|
| Interferon Type I | 1 | 2019 | 18 | 0.150 |
Why?
|
| RNA Viruses | 1 | 2019 | 22 | 0.150 |
Why?
|
| RNA, Transfer | 1 | 2019 | 29 | 0.150 |
Why?
|
| Mason-Pfizer monkey virus | 1 | 2018 | 1 | 0.140 |
Why?
|
| Transfection | 5 | 2014 | 532 | 0.140 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2009 | 296 | 0.140 |
Why?
|
| Virus Assembly | 1 | 2018 | 44 | 0.140 |
Why?
|
| Animals | 10 | 2016 | 16992 | 0.140 |
Why?
|
| Terminal Repeat Sequences | 1 | 2017 | 8 | 0.140 |
Why?
|
| Cysteine | 1 | 2018 | 103 | 0.140 |
Why?
|
| Capsid Proteins | 1 | 2018 | 76 | 0.140 |
Why?
|
| Histone Chaperones | 1 | 2017 | 1 | 0.140 |
Why?
|
| Kinetics | 1 | 2019 | 695 | 0.140 |
Why?
|
| HIV Core Protein p24 | 1 | 2016 | 12 | 0.130 |
Why?
|
| Histones | 2 | 2016 | 197 | 0.130 |
Why?
|
| Pyrrolidines | 1 | 2016 | 31 | 0.130 |
Why?
|
| Cell Line, Tumor | 1 | 2024 | 2676 | 0.130 |
Why?
|
| Protein Processing, Post-Translational | 2 | 2010 | 185 | 0.120 |
Why?
|
| Drug Resistance, Viral | 1 | 2016 | 67 | 0.120 |
Why?
|
| Gene Deletion | 2 | 2009 | 168 | 0.120 |
Why?
|
| HIV Infections | 3 | 2024 | 2586 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2016 | 61 | 0.120 |
Why?
|
| DNA Replication | 1 | 2016 | 148 | 0.110 |
Why?
|
| Drosophila | 1 | 2016 | 152 | 0.110 |
Why?
|
| Jurkat Cells | 2 | 2012 | 87 | 0.110 |
Why?
|
| Gene Products, rev | 2 | 2004 | 4 | 0.110 |
Why?
|
| T-Lymphocytes | 2 | 2009 | 386 | 0.100 |
Why?
|
| Genetic Vectors | 2 | 2018 | 165 | 0.100 |
Why?
|
| Leukemia Virus, Murine | 1 | 2012 | 3 | 0.100 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 2012 | 7 | 0.100 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2014 | 165 | 0.100 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 53 | 0.100 |
Why?
|
| DNA | 2 | 2005 | 592 | 0.090 |
Why?
|
| Molecular Sequence Data | 3 | 2009 | 1542 | 0.090 |
Why?
|
| Mutation | 3 | 2018 | 1177 | 0.090 |
Why?
|
| Protein Structure, Tertiary | 3 | 2009 | 423 | 0.090 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2011 | 41 | 0.090 |
Why?
|
| Mutant Proteins | 1 | 2011 | 51 | 0.090 |
Why?
|
| Proviruses | 2 | 2018 | 35 | 0.080 |
Why?
|
| Half-Life | 1 | 2010 | 63 | 0.080 |
Why?
|
| Immunoblotting | 2 | 2014 | 181 | 0.080 |
Why?
|
| Amino Acid Substitution | 1 | 2010 | 135 | 0.080 |
Why?
|
| Papillomavirus Infections | 1 | 2014 | 376 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2014 | 367 | 0.070 |
Why?
|
| Amino Acid Sequence | 2 | 2009 | 1180 | 0.070 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2014 | 652 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2005 | 883 | 0.070 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily D | 2 | 2025 | 2 | 0.070 |
Why?
|
| Infectious Anemia Virus, Equine | 1 | 2007 | 1 | 0.070 |
Why?
|
| rev Gene Products, Human Immunodeficiency Virus | 2 | 2004 | 3 | 0.070 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2014 | 968 | 0.070 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2005 | 60 | 0.070 |
Why?
|
| Virulence | 1 | 2007 | 246 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2004 | 127 | 0.060 |
Why?
|
| Mice | 5 | 2009 | 6644 | 0.060 |
Why?
|
| Chromosomes, Human | 1 | 2006 | 37 | 0.060 |
Why?
|
| Protein Structure, Secondary | 1 | 2006 | 182 | 0.060 |
Why?
|
| Amino Acids | 1 | 2006 | 148 | 0.060 |
Why?
|
| Viral Matrix Proteins | 1 | 2025 | 18 | 0.060 |
Why?
|
| Peptide Fragments | 2 | 2009 | 307 | 0.060 |
Why?
|
| Immunodeficiency Virus, Feline | 1 | 2004 | 2 | 0.060 |
Why?
|
| Interleukin-2 | 1 | 2025 | 91 | 0.060 |
Why?
|
| Macrophages | 1 | 2009 | 529 | 0.050 |
Why?
|
| Immunoprecipitation | 1 | 2004 | 127 | 0.050 |
Why?
|
| Protease Inhibitors | 1 | 2004 | 54 | 0.050 |
Why?
|
| Introns | 1 | 2004 | 79 | 0.050 |
Why?
|
| Genes, vpu | 1 | 2004 | 1 | 0.050 |
Why?
|
| Genes, vif | 1 | 2004 | 1 | 0.050 |
Why?
|
| Cytoplasm | 1 | 2004 | 154 | 0.050 |
Why?
|
| Ubiquitin | 1 | 2004 | 81 | 0.050 |
Why?
|
| Microscopy, Confocal | 1 | 2004 | 224 | 0.050 |
Why?
|
| Microscopy, Fluorescence | 1 | 2004 | 256 | 0.050 |
Why?
|
| Plasmids | 1 | 2004 | 244 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2025 | 206 | 0.050 |
Why?
|
| Lymphocyte Activation | 1 | 2004 | 249 | 0.050 |
Why?
|
| Respirovirus | 1 | 2002 | 3 | 0.050 |
Why?
|
| HIV-2 | 1 | 2002 | 9 | 0.050 |
Why?
|
| Defective Viruses | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2004 | 383 | 0.050 |
Why?
|
| Caveolin 1 | 1 | 2002 | 33 | 0.050 |
Why?
|
| Protein Sorting Signals | 1 | 2002 | 25 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2002 | 196 | 0.050 |
Why?
|
| Herpesvirus 4, Human | 1 | 2002 | 36 | 0.050 |
Why?
|
| HLA Antigens | 1 | 2002 | 27 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2002 | 26 | 0.050 |
Why?
|
| Lectins, C-Type | 1 | 2002 | 37 | 0.050 |
Why?
|
| Reverse Transcription | 1 | 2021 | 23 | 0.050 |
Why?
|
| Peptides | 1 | 2025 | 372 | 0.040 |
Why?
|
| Trans-Activators | 1 | 2002 | 192 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2004 | 561 | 0.040 |
Why?
|
| Nucleosomes | 1 | 2017 | 30 | 0.030 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2017 | 45 | 0.030 |
Why?
|
| Base Sequence | 2 | 2009 | 983 | 0.030 |
Why?
|
| HIV Protease | 1 | 2016 | 23 | 0.030 |
Why?
|
| Cations | 1 | 2016 | 50 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2016 | 245 | 0.030 |
Why?
|
| Structure-Activity Relationship | 1 | 2016 | 506 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2004 | 2157 | 0.030 |
Why?
|
| Molecular Structure | 1 | 2016 | 570 | 0.030 |
Why?
|
| Papillomavirus E7 Proteins | 1 | 2014 | 17 | 0.030 |
Why?
|
| Oncogene Proteins, Viral | 1 | 2014 | 25 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2016 | 1124 | 0.030 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2004 | 34 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 436 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2014 | 934 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 2 | 2004 | 306 | 0.020 |
Why?
|
| Repressor Proteins | 1 | 2014 | 273 | 0.020 |
Why?
|
| Intracellular Fluid | 1 | 2008 | 26 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 209 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2007 | 21 | 0.020 |
Why?
|
| Cell Culture Techniques | 1 | 2008 | 152 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2005 | 64 | 0.010 |
Why?
|
| Genes, Regulator | 1 | 2005 | 27 | 0.010 |
Why?
|
| NIH 3T3 Cells | 1 | 2005 | 64 | 0.010 |
Why?
|
| Cats | 1 | 2005 | 82 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2005 | 154 | 0.010 |
Why?
|
| Vero Cells | 1 | 2005 | 112 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2004 | 52 | 0.010 |
Why?
|
| COS Cells | 1 | 2004 | 68 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 2004 | 51 | 0.010 |
Why?
|
| Protein Transport | 1 | 2005 | 296 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2004 | 137 | 0.010 |
Why?
|
| Cell Cycle | 1 | 2005 | 346 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2004 | 411 | 0.010 |
Why?
|
| HLA-C Antigens | 1 | 2002 | 5 | 0.010 |
Why?
|
| beta 2-Microglobulin | 1 | 2002 | 10 | 0.010 |
Why?
|
| HLA-A Antigens | 1 | 2002 | 7 | 0.010 |
Why?
|
| HLA-B Antigens | 1 | 2002 | 11 | 0.010 |
Why?
|
| Clone Cells | 1 | 2002 | 50 | 0.010 |
Why?
|
| Biopolymers | 1 | 2002 | 17 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2002 | 82 | 0.010 |
Why?
|
| Calcium | 1 | 2004 | 491 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2004 | 986 | 0.010 |
Why?
|
| Killer Cells, Natural | 1 | 2002 | 104 | 0.010 |
Why?
|
| Membrane Glycoproteins | 1 | 2002 | 224 | 0.010 |
Why?
|
| Cytokines | 1 | 2004 | 678 | 0.010 |
Why?
|
| Female | 1 | 2014 | 24698 | 0.010 |
Why?
|